Last reviewed · How we verify

NCT06665503: AAD

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

Completed NA Last updated 12 November 2024
What this trial tests

NA trial testing Zinc Supplement, probiotic in Antibiotic-associated Diarrhea in 165 participants. Completed in 1 May 2021.

Timeline
1 September 2020
Primary endpoint
1 March 2021
1 May 2021

Quick facts

Lead sponsorHormozgan University of Medical Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment165
Start date1 September 2020
Primary completion1 March 2021
Estimated completion1 May 2021
Sites1 location across Iran

Drugs / interventions tested

Conditions studied

Sponsor

Hormozgan University of Medical Sciences

Who can join

Adults 3 Months to 3, any sex, with Antibiotic-associated Diarrhea or Diarrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Antibiotic-associated Diarrhea

Currently open trials in the same condition.

Other Hormozgan University of Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06665503.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing